Molecular Docking of Anti Helicobacter pylori Antibiotics and Proton Pump Inhibitor: A Single Center Survey (original) (raw)
Molecular docking, pharmacophore based virtual screening and molecular dynamics studies towards the identification of potential leads for the management of H. pylori
Rohidas Arote
RSC Advances, 2019
View PDFchevron_right
Computer-Aided Drug Discovery for Helicobacter pylori
Nicole Vita
2023
View PDFchevron_right
In silico probing exercises, bioactive-conformational and dynamic simulations strategies for designing and promoting selective therapeutics against Helicobacter pylori strains
Sudheer Kumar Katari
Journal of Molecular Graphics and Modelling, 2019
View PDFchevron_right
Design and Molecular Docking Studies of PIPERIDIN-4-ONE Derivative as Active Agent Against Helicobacter Pylori Infection
Winfred Jebaraj J
Journal of Advanced Scientific Research
View PDFchevron_right
Hierarchical-Clustering, Scaffold-Mining Exercises and Dynamics Simulations for Effectual Inhibitors Against Lipid-A Biosynthesis of Helicobacter pylori
Sudheer Kumar Katari
Cellular and Molecular Bioengineering, 2019
View PDFchevron_right
Structure-based inhibitor discovery of Helicobacter pylori dehydroquinate synthase
jaishin Liu
Biochemical and Biophysical Research Communications, 2008
View PDFchevron_right
Quantitative Structure-Activity Relationship and Molecular Docking Studies of Hydroxamic Acid Derivatives as Novel Class Inhibitors Against Helicobacter Pylori Urease
Tijjani Ibrahim
The Journal of Engineering and Exact Sciences
View PDFchevron_right
In silico approach towards the identification of potential inhibitors from Curcuma amada Roxb against H. pylori: ADMET screening and molecular docking studies
Subramaniam Sundareshan
BioImpacts
View PDFchevron_right
A Systematic in-silico Analysis of Helicobacter pylori Pathogenic Islands for Identification of Novel Drug Target Candidates
Deepthi Nammi
Current Genomics, 2017
View PDFchevron_right
Identification of Potential Drug Targets in Helicobacter pylori Strain HPAG1 by in silico Genome Analysis
Kareem Adel
Infectious Disorders - Drug Targets, 2015
View PDFchevron_right
Modeling studies of arginase from Helicobacter pylori divulge novel inhibitor-protein interactions
Kapil Patil
Clinical Proteomics and Bioinformatics, 2016
View PDFchevron_right
Inhibiting Helicobacter pylori HtrA protease by addressing a computationally predicted allosteric ligand binding site
Max Pillong
Chemical Science, 2014
View PDFchevron_right
Discovery of antiadhesins of Helicobacter pylori from existing drugs and medicines for malaria ventures pathogen box compounds
Ikemefuna Uzochukwu
GSC Biological and Pharmaceutical Sciences
View PDFchevron_right
Large-scale virtual screening for the identification of new Helicobacter pylori urease inhibitor scaffolds
homa azizian
Journal of Molecular Modeling, 2011
View PDFchevron_right
Integration of core hopping, quantum-mechanics, molecular mechanics coupled binding-energy estimations and dynamic simulations for fragment-based novel therapeutic scaffolds against Helicobacter pylori strains
Sudheer Kumar Katari
Computational Biology and Chemistry, 2019
View PDFchevron_right
Identification of Drug Target Properties and its validation on Helicobacter pylori
Kapil lakhawat
Canadian Journal of Biotechnology, 2017
View PDFchevron_right
Integrative computational protocol for the discovery of inhibitors of the Helicobacter pylori nickel response regulator (NikR)
Mario Rodríguez-pérez
Journal of Molecular Modeling, 2011
View PDFchevron_right
Computational Molecular Docking Methods in Drug Discovery: Recent Advances and Software
Rutuja Sonawane
European Chemical Bulletin, 2023
View PDFchevron_right
Inhibitors of Helicobacter pylori Protease HtrA Found by ‘Virtual Ligand’ Screening Combat Bacterial Invasion of Epithelia
Paul Wrede
PLoS ONE, 2011
View PDFchevron_right
MOLECULAR DOCKING AND ITS APPLICATION TOWARDS MODERN DRUG DISCOVERY
Dr Satyender Kumar
View PDFchevron_right
A proton pump inhibitor, E3810, has an antibacterial activity through binding to Helicobacter pylori
Takeshi Azuma
Gastroenterology, 1995
View PDFchevron_right
Fragment-Based De Novo Design Reveals a Small-Molecule Inhibitor of Helicobacter Pylori HtrA
anna perna
Angewandte Chemie (International ed. in English), 2015
View PDFchevron_right
Synthesis, molecular docking and kinetic properties of b-hydroxy-b- phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors
zhu-ping xiao
View PDFchevron_right
Molecular Docking in Drug Discovery
Dr. Santosh R Butle, Rani Bhagat
Journal of Pharmaceutical Research, 2021
View PDFchevron_right
Discovering Potent Inhibitors Against the β-Hydroxyacyl-Acyl Carrier Protein Dehydratase (FabZ) of Helicobacter pylori: Structure-Based Design, Synthesis, Bioassay, and Crystal Structure Determination
Mingyue Zheng
Journal of Medicinal Chemistry, 2009
View PDFchevron_right
Computational Docking Technique for Drug Discovery: A Review
RUPA MAZUMDER
Research Journal of Pharmacy and Technology
View PDFchevron_right
Multistep Synthesis of Fluorine-Substituted Pyrazolopyrimidine Derivatives With Higher Antibacterial Efficacy Based on In Vitro Molecular Docking and Density Functional Theory
Dr Kamlesh Sharma
Journal of Heterocyclic Chemistry, 2017
View PDFchevron_right